Effect of inhaled fluticasone on lung function in infants with recurrent wheezing: a randomised controlled trial

We conclude that once-daily treatment with 375 μg fluticasone increased forced flows and controlled symptoms in infants with recurrent wheezing without altering plasma cortisol levels. The spirometry-like technique is a useful tool to objectively assess the efficacy of anti-asthma medications in infants with repeated troublesome asthma-like symptoms.